Cargando…

PA28γ, an Accomplice to Malignant Cancer

PA28γ is a nuclear activator of the 20S proteasome, which is involved in the regulation of several essential cellular processes and angiogenesis. Over the past 20 years, many amino acid sites and motifs have been proven to play important roles in the characteristic functions of PA28γ. The number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Kexin, Bai, Hetian, Sun, Silu, Xin, Chuan, Li, Jing, Chen, Qianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662426/
https://www.ncbi.nlm.nih.gov/pubmed/33194729
http://dx.doi.org/10.3389/fonc.2020.584778
_version_ 1783609396687798272
author Lei, Kexin
Bai, Hetian
Sun, Silu
Xin, Chuan
Li, Jing
Chen, Qianming
author_facet Lei, Kexin
Bai, Hetian
Sun, Silu
Xin, Chuan
Li, Jing
Chen, Qianming
author_sort Lei, Kexin
collection PubMed
description PA28γ is a nuclear activator of the 20S proteasome, which is involved in the regulation of several essential cellular processes and angiogenesis. Over the past 20 years, many amino acid sites and motifs have been proven to play important roles in the characteristic functions of PA28γ. The number of binding partners and validated cellular functions of PA28γ have increased, which has facilitated the clarification of its involvement in different biological events. PA28γ is involved in the progression of various diseases, and its aberrant overexpression in cancer is remarkable. Patients with low levels of PA28γ expression have a higher survival rate than those with high levels of PA28γ expression, as has been shown for a wide variety of tumors. The functions of PA28γ in cancer can be divided into five main categories: cell proliferation, cell apoptosis, metastasis and invasion, cell nuclear dynamics that have relevance to angiogenesis, and viral infection. In this review, we focus on the role of PA28γ in cancer, summarizing its aberrant expression, prooncogenic effects and underlying mechanisms in various cancers, and we highlight the possible cancer-related applications of PA28γ, such as its potential use in the diagnosis, targeted treatment and prognostic assessment of cancer.
format Online
Article
Text
id pubmed-7662426
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76624262020-11-13 PA28γ, an Accomplice to Malignant Cancer Lei, Kexin Bai, Hetian Sun, Silu Xin, Chuan Li, Jing Chen, Qianming Front Oncol Oncology PA28γ is a nuclear activator of the 20S proteasome, which is involved in the regulation of several essential cellular processes and angiogenesis. Over the past 20 years, many amino acid sites and motifs have been proven to play important roles in the characteristic functions of PA28γ. The number of binding partners and validated cellular functions of PA28γ have increased, which has facilitated the clarification of its involvement in different biological events. PA28γ is involved in the progression of various diseases, and its aberrant overexpression in cancer is remarkable. Patients with low levels of PA28γ expression have a higher survival rate than those with high levels of PA28γ expression, as has been shown for a wide variety of tumors. The functions of PA28γ in cancer can be divided into five main categories: cell proliferation, cell apoptosis, metastasis and invasion, cell nuclear dynamics that have relevance to angiogenesis, and viral infection. In this review, we focus on the role of PA28γ in cancer, summarizing its aberrant expression, prooncogenic effects and underlying mechanisms in various cancers, and we highlight the possible cancer-related applications of PA28γ, such as its potential use in the diagnosis, targeted treatment and prognostic assessment of cancer. Frontiers Media S.A. 2020-10-30 /pmc/articles/PMC7662426/ /pubmed/33194729 http://dx.doi.org/10.3389/fonc.2020.584778 Text en Copyright © 2020 Lei, Bai, Sun, Xin, Li and Chen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lei, Kexin
Bai, Hetian
Sun, Silu
Xin, Chuan
Li, Jing
Chen, Qianming
PA28γ, an Accomplice to Malignant Cancer
title PA28γ, an Accomplice to Malignant Cancer
title_full PA28γ, an Accomplice to Malignant Cancer
title_fullStr PA28γ, an Accomplice to Malignant Cancer
title_full_unstemmed PA28γ, an Accomplice to Malignant Cancer
title_short PA28γ, an Accomplice to Malignant Cancer
title_sort pa28γ, an accomplice to malignant cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662426/
https://www.ncbi.nlm.nih.gov/pubmed/33194729
http://dx.doi.org/10.3389/fonc.2020.584778
work_keys_str_mv AT leikexin pa28ganaccomplicetomalignantcancer
AT baihetian pa28ganaccomplicetomalignantcancer
AT sunsilu pa28ganaccomplicetomalignantcancer
AT xinchuan pa28ganaccomplicetomalignantcancer
AT lijing pa28ganaccomplicetomalignantcancer
AT chenqianming pa28ganaccomplicetomalignantcancer